UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:NF1-CCDC47 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: NF1-CCDC47 | FusionPDB ID: 58675 | FusionGDB2.0 ID: 58675 | Hgene | Tgene | Gene symbol | NF1 | CCDC47 | Gene ID | 4763 | 57003 |
Gene name | neurofibromin 1 | coiled-coil domain containing 47 | |
Synonyms | NFNS|VRNF|WSS | GK001|MSTP041|THNS | |
Cytomap | 17q11.2 | 17q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | neurofibrominneurofibromatosis 1neurofibromatosis-related protein NF-1truncated neurofibromin 1 | coiled-coil domain-containing protein 47Calumin | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | P21359 | Q96A33 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000358273, ENST00000356175, ENST00000417592, ENST00000431387, ENST00000444181, ENST00000581113, | ENST00000582252, ENST00000403162, ENST00000225726, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 47 X 26 X 21=25662 | 8 X 7 X 5=280 |
# samples | 69 | 8 | |
** MAII score | log2(69/25662*10)=-5.21689344093196 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/280*10)=-1.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: NF1 [Title/Abstract] AND CCDC47 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | NF1(29580018)-CCDC47(61824321), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | NF1-CCDC47 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-CCDC47 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-CCDC47 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-CCDC47 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-CCDC47 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. NF1-CCDC47 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. NF1-CCDC47 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NF1 | GO:0043547 | positive regulation of GTPase activity | 2121371 |
Fusion gene breakpoints across NF1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CCDC47 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | HNSC | TCGA-CQ-7069 | NF1 | chr17 | 29580018 | + | CCDC47 | chr17 | 61824321 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000358273 | NF1 | chr17 | 29580018 | + | ENST00000225726 | CCDC47 | chr17 | 61824321 | - | 6268 | 4556 | 254 | 4636 | 1460 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000358273 | ENST00000225726 | NF1 | chr17 | 29580018 | + | CCDC47 | chr17 | 61824321 | - | 0.000278003 | 0.99972194 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >58675_58675_1_NF1-CCDC47_NF1_chr17_29580018_ENST00000358273_CCDC47_chr17_61824321_ENST00000225726_length(amino acids)=1460AA_BP=1434 MGACTPQTLSLPLPSPQPPLPALFPAQGAGPPFPPPPPGRGEDMAAHRPVEWVQAVVSRFDEQLPIKTGQQNTHTKVSTEHNKECLINIS KYKFSLVISGLTTILKNVNNMRIFGEAAEKNLYLSQLIILDTLEKCLAGQPKDTMRLDETMLVKQLLPEICHFLHTCREGNQHAAELRNS ASGVLFSLSCNNFNAVFSRISTRLQELTVCSEDNVDVHDIELLQYINVDCAKLKRLLKETAFKFKALKKVAQLAVINSLEKAFWNWVENY PDEFTKLYQIPQTDMAECAEKLFDLVDGFAESTKRKAAVWPLQIILLILCPEIIQDISKDVVDENNMNKKLFLDSLRKALAGHGGSRQLT ESAAIACVKLCKASTYINWEDNSVIFLLVQSMVVDLKNLLFNPSKPFSRGSQPADVDLMIDCLVSCFRISPHNNQHFKICLAQNSPSTFH YVLVNSLHRIITNSALDWWPKIDAVYCHSVELRNMFGETLHKAVQGCGAHPAIRMAPSLTFKEKVTSLKFKEKPTDLETRSYKYLLLSMV KLIHADPKLLLCNPRKQGPETQGSTAELITGLVQLVPQSHMPEIAQEAMEALLVLHQLDSIDLWNPDAPVETFWEISSQMLFYICKKLTS HQMLSSTEILKWLREILICRNKFLLKNKQADRSSCHFLLFYGVGCDIPSSGNTSQMSMDHEELLRTPGASLRKGKGNSSMDSAAGCSGTP PICRQAQTKLEVALYMFLWNPDTEAVLVAMSCFRHLCEEADIRCGVDEVSVHNLLPNYNTFMEFASVSNMMSTGRAALQKRVMALLRRIE HPTAGNTEAWEDTHAKWEQATKLILNYPKAKMEDGQAAESLHKTIVKRRMSHVSGGGSIDLSDTDSLQEWINMTGFLCALGGVCLQQRSN SGLATYSPPMGPVSERKGSMISVMSSEGNADTPVSKFMDRLLSLMVCNHEKVGLQIRTNVKDLVGLELSPALYPMLFNKLKNTISKFFDS QGQVLLTDTNTQFVEQTIAIMKNLLDNHTEGSSEHLGQASIETMMLNLVRYVRVLGNMVHAIQIKTKLCQLVEVMMARRDDLSFCQEMKF RNKMVEYLTDWVMGTSNQAADDDVKCLTRDLDQASMEAVVSLLAGLPLQPEEGDGVELMEAKSQLFLKYFTLFMNLLNDCSEVEDESAQT GGRKRGMSRRLASLRHCTVLAMSNLLNANVDSGLMHSIGLGYHKDLQTRATFMEVLTKILQQGTEFDTLAETVLADRFERLVELVTMMGD QGELPIAMALANVVPCSQWDELARVLVTLFDSRHLLYQLLWNMFSKEVELADSMQTLFRGNSLASKIMTFCFKVYGATYLQKLLDPLLRI VITSSDWQHVSFEVDPTRLEPSESLEENQRNLLQMTEKFFHAIISSSSEFPPQLRSVCHCLYQATCHSLLNKATVKEKKENKKSEAALRR -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:29580018/chr17:61824321) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NF1 | CCDC47 |
FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}. | FUNCTION: Component of the PAT complex, an endoplasmic reticulum (ER)-resident membrane multiprotein complex that facilitates multi-pass membrane proteins insertion into membranes (PubMed:32814900). The PAT complex acts as an intramembrane chaperone by directly interacting with nascent transmembrane domains (TMDs), releasing its substrates upon correct folding, and is needed for optimal biogenesis of multi-pass membrane proteins (PubMed:32814900). WDR83OS/Asterix is the substrate-interacting subunit of the PAT complex, whereas CCDC47 is required to maintain the stability of WDR83OS/Asterix (PubMed:32814900). The PAT complex favors the binding to TMDs with exposed hydrophilic amino acids within the lipid bilayer and provides a membrane-embedded partially hydrophilic environment in which the first transmembrane domain binds (PubMed:32814900). Component of a ribosome-associated ER translocon complex involved in multi-pass membrane protein transport into the ER membrane and biogenesis (PubMed:32820719). Involved in the regulation of calcium ion homeostasis in the ER (PubMed:30401460). Required for proper protein degradation via the ERAD (ER-associated degradation) pathway (PubMed:25009997). Has an essential role in the maintenance of ER organization during embryogenesis (By similarity). {ECO:0000250|UniProtKB:Q9D024, ECO:0000269|PubMed:25009997, ECO:0000269|PubMed:30401460, ECO:0000269|PubMed:32814900, ECO:0000269|PubMed:32820719}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000358273 | + | 31 | 58 | 1352_1355 | 1391.0 | 2840.0 | Compositional bias | Note=Poly-Ser |
Tgene | CCDC47 | chr17:29580018 | chr17:61824321 | ENST00000582252 | 0 | 12 | 450_483 | 0 | 481.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | CCDC47 | chr17:29580018 | chr17:61824321 | ENST00000582252 | 0 | 12 | 136_155 | 0 | 481.0 | Transmembrane | Helical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000356175 | + | 1 | 57 | 1352_1355 | 0 | 2819.0 | Compositional bias | Note=Poly-Ser |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000431387 | + | 1 | 15 | 1352_1355 | 0 | 594.0 | Compositional bias | Note=Poly-Ser |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000356175 | + | 1 | 57 | 1235_1451 | 0 | 2819.0 | Domain | Ras-GAP |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000356175 | + | 1 | 57 | 1580_1738 | 0 | 2819.0 | Domain | CRAL-TRIO |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000358273 | + | 31 | 58 | 1235_1451 | 1391.0 | 2840.0 | Domain | Ras-GAP |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000358273 | + | 31 | 58 | 1580_1738 | 1391.0 | 2840.0 | Domain | CRAL-TRIO |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000431387 | + | 1 | 15 | 1235_1451 | 0 | 594.0 | Domain | Ras-GAP |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000431387 | + | 1 | 15 | 1580_1738 | 0 | 594.0 | Domain | CRAL-TRIO |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000356175 | + | 1 | 57 | 2555_2571 | 0 | 2819.0 | Motif | Note=Bipartite nuclear localization signal |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000358273 | + | 31 | 58 | 2555_2571 | 1391.0 | 2840.0 | Motif | Note=Bipartite nuclear localization signal |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000431387 | + | 1 | 15 | 2555_2571 | 0 | 594.0 | Motif | Note=Bipartite nuclear localization signal |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000356175 | + | 1 | 57 | 1580_1837 | 0 | 2819.0 | Region | Note=Lipid binding |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000358273 | + | 31 | 58 | 1580_1837 | 1391.0 | 2840.0 | Region | Note=Lipid binding |
Hgene | NF1 | chr17:29580018 | chr17:61824321 | ENST00000431387 | + | 1 | 15 | 1580_1837 | 0 | 594.0 | Region | Note=Lipid binding |
Tgene | CCDC47 | chr17:29580018 | chr17:61824321 | ENST00000225726 | 11 | 13 | 450_483 | 457.0 | 484.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | CCDC47 | chr17:29580018 | chr17:61824321 | ENST00000403162 | 12 | 14 | 450_483 | 457.0 | 484.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | CCDC47 | chr17:29580018 | chr17:61824321 | ENST00000225726 | 11 | 13 | 136_155 | 457.0 | 484.0 | Transmembrane | Helical | |
Tgene | CCDC47 | chr17:29580018 | chr17:61824321 | ENST00000403162 | 12 | 14 | 136_155 | 457.0 | 484.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
NF1 | HRAS, SMARCA4, POLR2A, TIRAP, SIRT7, VCP, NSFL1C, CAV1, YWHAB, FAF2, NXF1, CCDC8, HLA-DPA1, EFNB2, CD274, TNFSF13B, CA14, SLAMF1, VSIG4, TGOLN2, HTR6, NOSIP, KRAS, CLK1, CDC5L, APP, YWHAH, PML, TRAF6, PTEN, SDC2, EGFR, CD79B, P4HA3, SCN3B, VSIG1, SIGLECL1, EPHA1, FAM174A, KCTD3, KIF13B, ZBTB21, KSR1, CGN, GIGYF1, LRFN1, RTKN, MAST3, DENND1A, SH3PXD2A, SRGAP2, DENND4C, PPM1H, EIF4E2, SIPA1L1, LIMA1, RALGPS2, MAGI1, CBY1, TESK2, CDC25C, DCLK1, GIGYF2, HDAC4, LPIN3, ZNF638, CAMSAP2, NADK, MAPKAP1, SRSF12, RASAL2, SYDE1, KIAA1804, TIAM1, AGAP1, CDC25B, CDK16, SH3RF3, PHLDB2, PLEKHA7, KIF1C, OSBPL6, FAM110B, USP21, NAV1, TANC2, PTPN13, FAM53C, ANKRD34A, STARD13, PTPN14, GAB2, DENND4A, INPP5E, TOP1, TOP2A, TOP3A, NRAS, ZUFSP, ESR2, LZTR1, SPRED1, MYC, LIMK2, KIAA1429, CTDP1, DYRK1A, F12, AKT1, EPHA2, MAP2K3, RAF1, SOX4, BIRC3, ORF7a, LCK, NOLC1, N, nsp7, KIF14, PRC1, MKI67, FASN, NR3C1, DDRGK1, FLOT1, LYN, PFN1, RHOB, ATG7, EFS, C19orf38, CDHR2, ITFG3, CD80, SEMA4C, DGCR2, EFNA4, PTGES2, LRRC25, EVI2A, EFNB1, TPST2, C3orf18, GYPA, HCST, TACSTD2, OPALIN, IL2RA, CD226, SIRT6, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
NF1 | |
CCDC47 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to NF1-CCDC47 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to NF1-CCDC47 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NF1 | C0027831 | Neurofibromatosis 1 | 44 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | NF1 | C1708353 | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 10 | CLINGEN |
Hgene | NF1 | C0349639 | Juvenile Myelomonocytic Leukemia | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | NF1 | C2931482 | Neurofibromatosis-Noonan syndrome | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | NF1 | C0553586 | Cafe-au-lait macules with pulmonary stenosis | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | NF1 | C0162678 | Neurofibromatoses | 3 | CGI;CTD_human;GENOMICS_ENGLAND |
Hgene | NF1 | C0004114 | Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0023467 | Leukemia, Myelocytic, Acute | 2 | CTD_human |
Hgene | NF1 | C0025202 | melanoma | 2 | CGI;CTD_human |
Hgene | NF1 | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Hgene | NF1 | C0205768 | Subependymal Giant Cell Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0206727 | Nerve Sheath Tumors | 2 | CTD_human |
Hgene | NF1 | C0280783 | Juvenile Pilocytic Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0280785 | Diffuse Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334579 | Anaplastic astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334580 | Protoplasmic astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334581 | Gemistocytic astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334582 | Fibrillary Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334583 | Pilocytic Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0338070 | Childhood Cerebral Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0547065 | Mixed oligoastrocytoma | 2 | CTD_human |
Hgene | NF1 | C0750935 | Cerebral Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0750936 | Intracranial Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0751689 | Peripheral Nerve Sheath Neoplasm | 2 | CTD_human |
Hgene | NF1 | C0751691 | Perineurioma | 2 | CTD_human |
Hgene | NF1 | C1704230 | Grade I Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C1834235 | NEUROFIBROMATOSIS, FAMILIAL SPINAL | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | NF1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Hgene | NF1 | C0001430 | Adenoma | 1 | CTD_human |
Hgene | NF1 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | NF1 | C0016057 | Fibrosarcoma | 1 | CTD_human |
Hgene | NF1 | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | NF1 | C0017638 | Glioma | 1 | CGI;CTD_human |
Hgene | NF1 | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Hgene | NF1 | C0023186 | Learning Disorders | 1 | CTD_human |
Hgene | NF1 | C0023827 | liposarcoma | 1 | CTD_human |
Hgene | NF1 | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Hgene | NF1 | C0026654 | Moyamoya Disease | 1 | GENOMICS_ENGLAND |
Hgene | NF1 | C0027809 | Neurilemmoma | 1 | CTD_human |
Hgene | NF1 | C0027830 | neurofibroma | 1 | CTD_human |
Hgene | NF1 | C0027962 | Melanocytic nevus | 1 | CTD_human |
Hgene | NF1 | C0028326 | Noonan Syndrome | 1 | GENOMICS_ENGLAND |
Hgene | NF1 | C0031511 | Pheochromocytoma | 1 | CTD_human |
Hgene | NF1 | C0035320 | Retinal Neovascularization | 1 | CTD_human |
Hgene | NF1 | C0205646 | Adenoma, Basal Cell | 1 | CTD_human |
Hgene | NF1 | C0205647 | Follicular adenoma | 1 | CTD_human |
Hgene | NF1 | C0205648 | Adenoma, Microcystic | 1 | CTD_human |
Hgene | NF1 | C0205649 | Adenoma, Monomorphic | 1 | CTD_human |
Hgene | NF1 | C0205650 | Papillary adenoma | 1 | CTD_human |
Hgene | NF1 | C0205651 | Adenoma, Trabecular | 1 | CTD_human |
Hgene | NF1 | C0205824 | Liposarcoma, Dedifferentiated | 1 | CTD_human |
Hgene | NF1 | C0205825 | Liposarcoma, Pleomorphic | 1 | CTD_human |
Hgene | NF1 | C0205944 | Sarcoma, Epithelioid | 1 | CTD_human |
Hgene | NF1 | C0205945 | Sarcoma, Spindle Cell | 1 | CTD_human |
Hgene | NF1 | C0259783 | mixed gliomas | 1 | CTD_human |
Hgene | NF1 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Hgene | NF1 | C0555198 | Malignant Glioma | 1 | CTD_human |
Hgene | NF1 | C0751262 | Adult Learning Disorders | 1 | CTD_human |
Hgene | NF1 | C0751263 | Learning Disturbance | 1 | CTD_human |
Hgene | NF1 | C0751265 | Learning Disabilities | 1 | CTD_human |
Hgene | NF1 | C0751374 | Schwannomatosis, Plexiform | 1 | CTD_human |
Hgene | NF1 | C0917816 | Mental deficiency | 1 | CTD_human |
Hgene | NF1 | C0917817 | Neurofibromatosis 3 | 1 | CTD_human |
Hgene | NF1 | C1257877 | Pheochromocytoma, Extra-Adrenal | 1 | CTD_human |
Hgene | NF1 | C1261473 | Sarcoma | 1 | CTD_human |
Hgene | NF1 | C1330966 | Developmental Academic Disorder | 1 | CTD_human |
Hgene | NF1 | C1370889 | Liposarcoma, well differentiated | 1 | CTD_human |
Hgene | NF1 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Hgene | NF1 | C3150928 | NF1 Microdeletion Syndrome | 1 | ORPHANET |
Hgene | NF1 | C3714756 | Intellectual Disability | 1 | CTD_human |